High-Impact Form 4 Intelligence
Real-time SEC insider trading data with advanced filtering. Free beta.
Total Buys (Filtered)
$0
$0
Total Sells (Filtered)
$9.9M
$9,919,819
| Ticker | Company | Reporting Owner | Date | Value (USD) | Type | Form 4 |
|---|---|---|---|---|---|---|
| NAMS |
NewAmsterdam Pharma Co N.V.
|
Director
Other
|
2026-03-09 | $513,118 | X | Form 4 |
|
NAMS
S
NewAmsterdam Pharma Co N.V.
Kastelein Johannes Jacob Pieter
• Officer • Chief Scientific Officer
10b5-1 SellΔOwn -59.4%
2026-03-09
$3,071,679Large
|
||||||
| NAMS |
NewAmsterdam Pharma Co N.V.
|
Officer • Chief Scientific Officer
10b5-1 SellΔOwn -59.4%
|
2026-03-09 | $3,071,679Large | S | Form 4 |
| NAMS |
NewAmsterdam Pharma Co N.V.
|
Director
Discretionary Sell
|
2026-03-06 | $828,950 | S | Form 4 |
|
NAMS
S
NewAmsterdam Pharma Co N.V.
Kastelein Johannes Jacob Pieter
• Officer • Chief Scientific Officer
10b5-1 SellΔOwn -57.6%
2026-03-06
$2,853,840Large
|
||||||
| NAMS |
NewAmsterdam Pharma Co N.V.
|
Officer • Chief Scientific Officer
10b5-1 SellΔOwn -57.6%
|
2026-03-06 | $2,853,840Large | S | Form 4 |
|
NAMS
S
NewAmsterdam Pharma Co N.V.
Kastelein Johannes Jacob Pieter
• Officer • Chief Scientific Officer
10b5-1 SellΔOwn -60.1%
2026-03-05
$3,165,350Large
|
||||||
| NAMS |
NewAmsterdam Pharma Co N.V.
|
Officer • Chief Scientific Officer
10b5-1 SellΔOwn -60.1%
|
2026-03-05 | $3,165,350Large | S | Form 4 |